We Intend to Disrupt the Optical Imaging Market
We aim to disrupt the optical imaging market by enabling fluorescence lifetime (FLT) based imaging of biological materials, cells, tissues, and organs in life sciences. To achieve this, we are designing, developing, manufacturing, and marketing a first-generation CAPS-based FLT camera developed at the VUB.
Plans for Taurion
We plan to spin out Taurion from the VUB to develop the necessary hardware for real-time in vivo FLT imaging in the NIR region. Additionally, we will develop the time-domain models and software needed to extract and objectify biological information, integrating these into fully functional imaging instruments for life sciences and in vivo preclinical research systems. Taurion will pioneer the development of a next-generation platform capable of revealing real-time, accurate information related to diseases in biological models through innovative FLT imaging technology. The time-domain or lifetime element of fluorescent light has the potential to disclose a wealth of new, valuable biological information when applied and coupled with the right dyes, probes, and supported by smart, user-friendly software.
The Growing Field of Optical Imaging
In life science research and clinical drug translation, preclinical optical imaging is an established and growing field. In clinical settings and personalized medicine, there is a growing need for safe diagnostic tools that can interrogate molecular and/or (patho)physiological parameters in real time, providing immediate feedback during medical interventions or continuous health monitoring. Among other modalities, optical imaging, combined with NIR fluorescence molecular tracers, offers a promising real-time solution.
Future Developments at the VUB
In the coming years, the development of NIR fluorescence lifetime imaging will advance into clinical applications such as Fluorescence Guided Surgery (FGS) at the VUB. This technology, when combined with the right dyes, probes, and algorithms, can provide real-time anatomical, functional, metabolic, or molecular information, positioning it at the forefront of in vivo patient imaging.
Our Vision
Pioneer real-time NIR time-domain fluorescence imaging in life sciences and clinical applications.
